Tracking Cathie Wood: Aggressively buying AI-driven pharmaceutical company RXRX, adding to Google; significantly reducing stake in ad tech stock TTD

Last Friday, after three consecutive days of suppressed selling, the US stock market saw an explosive emergence of 'buying the dip' sentiment, $S&P 500 Index (.SPX.US)$ marking the largest single-day gain since May of last year, $Dow Jones Industrial Average (.DJI.US)$and historically surpassing the 50,000-point mark.

Friday also marked another time the Dow broke through a major thousand-point threshold, after first crossing 40,000 points in May 2024. NVIDIA surged over 7% in a single day, adding more than $320 billion in market value, while Caterpillar, Goldman Sachs, JPMorgan, and other cyclical/value stocks continued to see capital inflows, pushing this nearly 130-year-old index to new highs.

In the trading on February 6th,ARK demonstrated a clear 'changing horses' strategy: heavily betting on AI-driven biotech and tech giants while significantly reducing holdings related to SaaS and ad tech.

Direction of increased positions: betting on biotech and AI

Last Friday, ARK’s buying focus was very clear, concentrated inAI pharmaceuticalsandtech giants, showing its long-term confidence in AI applications, especially in the healthcare sector.

1. Increasing positions in the two AI healthcare leaders

$Recursion Pharmaceuticals (RXRX.US)$: Adding 6.309 million shares,This was the largest buy of the day. RXRX uses machine learning to accelerate drug discovery and is a typical 'AI + biotech' concept stock. Such a large-scale increase shows that Cathie Wood believes this field is about to enter an explosive growth phase.

$Tempus AI (TEM.US)$Bought an additional 643 shares & $Canton Strategic Holdings (CNTN.US)$ Bought an additional 56,200 shares,Although the number of TEM shares purchased was small, combined with THAR's increased holdings, it strengthened ARK's positioning in the AI healthcare sector.

2. Positioning in tech giants and the crypto industry

$Alphabet-C (GOOG.US)$Bought 31,500 shares,In market volatility, adding to positions in Google, which has stable cash flow and powerful AI models, is seen as a 'stabilizer' in the investment portfolio, balancing the volatility of high-risk growth stocks.

Cathie Wood made a large purchase of a digital asset exchange, $Bullish (BLSH.US)$393,100 shares, indicating that although Coinbase was reduced, Cathie Wood has not abandoned the blockchain finance track but has switched targets.

Direction of reduction: Profit-taking and cutting software stocks

The sell-side focus is primarily on sectors that may face valuation correction pressures in the near term, including cloud computing monitoring, ad tech, and some cryptocurrency assets.

1. Significant reduction in SaaS

$PagerDuty (PD.US)$Sell-down277,900 shares,PagerDuty, as an IT incident response platform, was significantly reduced, possibly indicating ARK believes its short-term growth momentum has been priced in or that capital efficiency is lower compared to AI pharmaceutical stocks.

2. Ad tech and streaming media retreat

$The Trade Desk (TTD.US)$ Reduced by 144,000 shares & $Roku Inc (ROKU.US)$Reduced by 141,900 shares,TTD and ROKU have been long-term favorites in ARK's portfolio, but this synchronized reduction suggests 'Wooden Sister' (Cathie Wood) holds a cautious view toward the short-term recovery or competitive landscape of the digital advertising market.

3. Profit-taking adjustments in cryptocurrency concepts

$Coinbase (COIN.US)$Sold 134,500 shares,Although BLSH was bought, COIN was sold heavily. This is typically ARK's standard operation — making wave adjustments at high stock prices to lock in profits and shift funds towards undervalued targets.

Futubull's [Opportunities Page] has launched a feature to track celebrity portfolio opportunities! Choose from multiple celebrity portfolios, one-click follow the moves of top investors, precisely lock in high-quality stocks, and invest with greater confidence!

369K Views